BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8606928)

  • 1. p53, erbB-2 and K-ras gene alterations are rare in spontaneous and plutonium-239-induced canine lung neoplasia.
    Tierney LA; Hahn FF; Lechner JF
    Radiat Res; 1996 Feb; 145(2):181-7. PubMed ID: 8606928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 alterations in plutonium-induced F344 rat lung tumors.
    Kelly G; Stegelmeier BL; Hahn FF
    Radiat Res; 1995 Jun; 142(3):263-9. PubMed ID: 7761575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in Tp53 gene sequences from lung tumors in rats that inhaled plutonium dioxide.
    Yamada Y; Oghiso Y
    Radiat Res; 1999 Dec; 152(6 Suppl):S107-9. PubMed ID: 10564948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenic alterations in murine liver, lung, and uterine tumors induced by in utero exposure to ionizing radiation.
    Lumniczky K; Antal S; Unger E; Wunderlich L; Hidvégi EJ; Sáfrány G
    Mol Carcinog; 1998 Feb; 21(2):100-10. PubMed ID: 9496910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and K-ras in radon-associated lung adenocarcinoma.
    McDonald JW; Taylor JA; Watson MA; Saccomanno G; Devereux TR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):791-3. PubMed ID: 8672998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
    Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
    Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
    Wang Y; Zhang Z; Lubet R; You M
    Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
    Lehman TA; Bennett WP; Metcalf RA; Welsh JA; Ecker J; Modali RV; Ullrich S; Romano JW; Appella E; Testa JR
    Cancer Res; 1991 Aug; 51(15):4090-6. PubMed ID: 1855224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.